{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:44:37Z","timestamp":1791150277027,"version":"4.1.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,19]],"date-time":"2008-02-19T00:00:00Z","timestamp":1203379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10456-008-9101-9","type":"journal-article","created":{"date-parts":[[2008,2,18]],"date-time":"2008-02-18T10:37:34Z","timestamp":1203331054000},"page":"79-89","source":"Crossref","is-referenced-by-count":280,"title":["Endoglin in angiogenesis and vascular diseases"],"prefix":"10.1007","volume":"11","author":[{"given":"Peter","family":"ten Dijke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9","family":"Goumans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Pardali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,19]]},"reference":[{"key":"9101_CR1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4049\/jimmunol.136.1.118","volume":"136","author":"EJ Quackenbush","year":"2006","unstructured":"Quackenbush EJ, Gougos A, Baumal R, Letarte M (2006) Differential localization within human kidney of five membrane proteins expressed on acute lymphoblastic leukemia cells. J Immunol 136:118\u2013124","journal-title":"J Immunol"},{"key":"9101_CR2","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1016\/S0021-9258(19)38892-1","volume":"265","author":"A Gougos","year":"1990","unstructured":"Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361\u20138364","journal-title":"J Biol Chem"},{"key":"9101_CR3","first-page":"1623","volume":"1","author":"FJ Burrows","year":"1995","unstructured":"Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, Thorpe PE (1995) Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1:1623\u20131634","journal-title":"Clin Cancer Res"},{"key":"9101_CR4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.0.CO;2-X","volume":"81","author":"DW Miller","year":"1999","unstructured":"Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A, Sedlacek HH, M\u00fcller R, Adamkiewicz J (1999) Elevated expression of endoglin, a component of the TGF-\u03b2-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 81:568\u2013572","journal-title":"Int J Cancer"},{"key":"9101_CR5","first-page":"2037","volume":"6","author":"E Fonsatti","year":"2000","unstructured":"Fonsatti E, Jekunen AP, Kairemo KJ, Coral S, Snellman M, Nicotra MR, Natali PG, Altomonte M, Maio M (2000) Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res 6:2037\u20132043","journal-title":"Clin Cancer Res"},{"key":"9101_CR6","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.1016\/S0021-9258(18)41732-2","volume":"267","author":"S Cheifetz","year":"1992","unstructured":"Cheifetz S, Bell\u00f3n T, Cal\u00e9s C, Vera S, Bernabeu C, Massagu\u00e9 J, Letarte M (1992) Endoglin is a component of the transforming growth factor-\u03b2 receptor system in human endothelial cells. J Biol Chem 267:19027\u201319030","journal-title":"J Biol Chem"},{"key":"9101_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J et al (1994) Endoglin, a TGF-\u03b2 binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345\u2013351","journal-title":"Nat Genet"},{"key":"9101_CR8","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.284.5419.1534","volume":"284","author":"DY Li","year":"1999","unstructured":"Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP (1999) Defective angiogenesis in mice lacking endoglin. Science 284:1534\u20131537","journal-title":"Science"},{"key":"9101_CR9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI8088","volume":"104","author":"A Bourdeau","year":"1999","unstructured":"Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104:1343\u20131351","journal-title":"J Clin Invest"},{"key":"9101_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/dbio.1999.9534","volume":"217","author":"HM Arthur","year":"2000","unstructured":"Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Burn J, Diamond AG (2000) Endoglin, an ancillary TGF\u03b2 receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217:42\u201353","journal-title":"Dev Biol"},{"key":"9101_CR11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cardiores.2005.11.020","volume":"69","author":"M Jerkic","year":"2006","unstructured":"Jerkic M, Rodr\u00edguez-Barbero A, Prieto M, Toporsian M, Pericacho M, Rivas-Elena JV, Obreo J, Wang A, P\u00e9rez-Barriocanal F, Ar\u00e9valo M, Bernab\u00e9u C, Letarte M, L\u00f3pez-Novoa JM (2006) Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovasc Res 69:845\u2013854","journal-title":"Cardiovasc Res"},{"key":"9101_CR12","first-page":"1","volume":"28","author":"A D\u00fcwel","year":"2007","unstructured":"D\u00fcwel A, Eleno N, Jerkic M, Arevalo M, Bola\u00f1os JP, Bernabeu C, L\u00f3pez-Novoa JM (2007) Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice. Tumour Biol 28:1\u20138","journal-title":"Tumour Biol"},{"key":"9101_CR13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","volume":"2","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D\u2019Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2:642\u2013649","journal-title":"Nat Med"},{"key":"9101_CR14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P Dijke ten","year":"2007","unstructured":"ten Dijke P, Arthur HM (2007) Extracellular control of TGF\u03b2 signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857\u2013869","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9101_CR15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor \u03b2 in human disease. N Engl J Med 342:1350\u20131358","journal-title":"N Engl J Med"},{"key":"9101_CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","volume":"390","author":"CH Heldin","year":"1997","unstructured":"Heldin CH, Miyazono K, ten Dijke P (1997) TGF-\u03b2 signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465\u2013471","journal-title":"Nature"},{"key":"9101_CR17","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","volume":"8","author":"B Schmierer","year":"2007","unstructured":"Schmierer B, Hill CS (2007) TGF\u03b2-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8:970\u2013982","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9101_CR18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0092-8674(93)90489-D","volume":"75","author":"P Franz\u00e9n","year":"1993","unstructured":"Franz\u00e9n P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K (1993) Cloning of a TGF\u03b2 type I receptor that forms a heteromeric complex with the TGF\u03b2 type II receptor. Cell 75:681\u2013692","journal-title":"Cell"},{"key":"9101_CR19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","volume":"21","author":"MJ Goumans","year":"2002","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation state of the endothelium via two distinct TGF-\u03b2 type I receptors. EMBO J 21:1743\u20131753","journal-title":"EMBO J"},{"key":"9101_CR20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0092-8674(91)90549-E","volume":"65","author":"LS Mathews","year":"1991","unstructured":"Mathews LS, Vale WW (1991) Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973\u2013982","journal-title":"Cell"},{"key":"9101_CR21","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1128\/MCB.16.3.1066","volume":"16","author":"L Attisano","year":"1996","unstructured":"Attisano L, Wrana JL, Montalvo E, Massagu\u00e9 J (1996) Activation of signalling by the activin receptor complex. Mol Cell Biol 16:1066\u20131073","journal-title":"Mol Cell Biol"},{"key":"9101_CR22","doi-asserted-by":"crossref","first-page":"16985","DOI":"10.1016\/S0021-9258(17)32506-1","volume":"269","author":"P Dijke ten","year":"1994","unstructured":"ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin C-H, Miyazono K (1994) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269:16985\u201316988","journal-title":"J Biol Chem"},{"key":"9101_CR23","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1128\/MCB.15.7.3479","volume":"15","author":"F Liu","year":"1995","unstructured":"Liu F, Ventura F, Doody J, Massagu\u00e9 J (1995) Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15:3479\u20133486","journal-title":"Mol Cell Biol"},{"key":"9101_CR24","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1073\/pnas.92.17.7632","volume":"92","author":"BL Rosenzweig","year":"1995","unstructured":"Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632\u20137636","journal-title":"Proc Natl Acad Sci USA"},{"key":"9101_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1083\/jcb.130.1.217","volume":"130","author":"H Yamashita","year":"1995","unstructured":"Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin C-H, Miyazono K (1995) Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130:217\u2013226","journal-title":"J Cell Biol"},{"key":"9101_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","volume":"370","author":"JL Wrana","year":"1994","unstructured":"Wrana JL, Attisano L, Wieser R, Ventura F, Massagu\u00e9 J (1994) Mechanism of activation of the TGF-\u03b2 receptor. Nature 370:341\u2013347","journal-title":"Nature"},{"key":"9101_CR27","doi-asserted-by":"crossref","first-page":"27678","DOI":"10.1074\/jbc.272.44.27678","volume":"272","author":"S Abdollah","year":"1997","unstructured":"Abdollah S, Mac\u00edas-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL (1997) T\u03b2RI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272:27678\u201327685","journal-title":"J Biol Chem"},{"key":"9101_CR28","doi-asserted-by":"crossref","first-page":"28107","DOI":"10.1074\/jbc.272.44.28107","volume":"272","author":"S Souchelnytskyi","year":"1997","unstructured":"Souchelnytskyi S, Tamaki K, Engstr\u00f6m U, Wernstedt C, ten Dijke P, Heldin C-H (1997) Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-\u03b2 signaling. J Biol Chem 272:28107\u201328115","journal-title":"J Biol Chem"},{"key":"9101_CR29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0092-8674(00)81250-7","volume":"85","author":"PA Hoodless","year":"1986","unstructured":"Hoodless PA, Haerry T, Abdollah S, Stapleton M, O\u2019Connor MB, Attisano L, Wrana JL (1986) MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489\u2013500","journal-title":"Cell"},{"key":"9101_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)80128-2","volume":"86","author":"K Eppert","year":"1996","unstructured":"Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L (1996) MADR2 maps to 18q21 and encodes a TGF\u03b2-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543\u2013552","journal-title":"Cell"},{"key":"9101_CR31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/383168a0","volume":"383","author":"Y Zhang","year":"1996","unstructured":"Zhang Y, Feng X, We R, Derynck R (1996) Receptor-associated Mad homologues synergize as effectors of the TGF-\u03b2 response. Nature 383:168\u2013172","journal-title":"Nature"},{"key":"9101_CR32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/383832a0","volume":"383","author":"G Lagna","year":"1996","unstructured":"Lagna G, Hata A, Hemmati-Brivanlou A, Massagu\u00e9 J (1996) Partnership between DPC4 and SMAD proteins in TGF-\u03b2 signalling pathways. Nature 383:832\u2013836","journal-title":"Nature"},{"key":"9101_CR33","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1101\/gad.11.23.3157","volume":"11","author":"F Liu","year":"1997","unstructured":"Liu F, Pouponnot C, Massagu\u00e9 J (1997) Dual role of the Smad4\/DPC4 tumor suppressor in TGF\u03b2-inducible transcriptional complexes. Genes Dev 11:3157\u20133167","journal-title":"Genes Dev"},{"key":"9101_CR34","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1101\/gad.12.14.2153","volume":"12","author":"XH Feng","year":"1998","unstructured":"Feng XH, Zhang Y, Wu RY, Derynck R (1998) The tumor suppressor Smad4\/DPC4 and transcriptional adaptor CBP\/p300 are coactivators for smad3 in TGF-\u03b2-induced transcriptional activation. Genes Dev 12:2153\u20132163","journal-title":"Genes Dev"},{"key":"9101_CR35","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1083\/jcb.133.5.1109","volume":"133","author":"P Lastres","year":"1996","unstructured":"Lastres P, Letamend\u00eda A, Zhang H, Rius C, Almendro N, Raab U, L\u00f3pez LA, Langa C, Fabra A, Letarte M, Bernab\u00e9u C (1996) Endoglin modulates cellular responses to TGF-\u03b21. J Cell Biol 133:1109\u20131121","journal-title":"J Cell Biol"},{"key":"9101_CR36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardiores.2004.10.036","volume":"65","author":"F Lebrin","year":"2005","unstructured":"Lebrin F, Deckers M, Bertolino P, tn Dijke P (2005) TGF-\u03b2 receptor function in the endothelium. Cardiovasc Res 65:599\u2013608","journal-title":"Cardiovasc Res"},{"key":"9101_CR37","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/sj.onc.1208644","volume":"24","author":"E P\u00e9rez-G\u00f3mez","year":"2005","unstructured":"P\u00e9rez-G\u00f3mez E, Eleno N, L\u00f3pez-Novoa JM, Ramirez JR, Velasco B, Letarte M, Bernab\u00e9u C, Quintanilla M (2005) Characterization of murine S-endoglin isoform and its effects on tumor development. Oncogene 24:4450\u20134461","journal-title":"Oncogene"},{"key":"9101_CR38","doi-asserted-by":"crossref","unstructured":"Velasco S, Alvarez-Mu\u00f1oz P, Pericacho M, ten Dijke P, Bernabeu C, Lopez-Novoa JM, Rodriguez-Barbero A (2008) L- and S-endoglin differentially modulate transforming growth factor \u03b21 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J Cell Sci (in press)","DOI":"10.1242\/jcs.023283"},{"key":"9101_CR39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0092-8674(91)90074-9","volume":"67","author":"XF Wang","year":"1991","unstructured":"Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA (1991) Expression cloning and characterization of the TGF-\u03b2 type III receptor. Cell 67:797\u2013805","journal-title":"Cell"},{"key":"9101_CR40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0092-8674(91)90073-8","volume":"67","author":"F L\u00f3pez-Casillas","year":"1991","unstructured":"L\u00f3pez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massagu\u00e9 J (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-\u03b2 receptor system. Cell 67:785\u2013795","journal-title":"Cell"},{"key":"9101_CR41","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0092-8674(93)90368-Z","volume":"73","author":"F L\u00f3pez-Casillas","year":"1993","unstructured":"L\u00f3pez-Casillas F, Wrana JL, Massagu\u00e9 J (1993) Betaglycan presents ligand to the TGF\u03b2 signaling receptor. Cell 73:1435\u20131444","journal-title":"Cell"},{"key":"9101_CR42","doi-asserted-by":"crossref","first-page":"33011","DOI":"10.1074\/jbc.273.49.33011","volume":"273","author":"A Letamend\u00eda","year":"1998","unstructured":"Letamend\u00eda A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C (1998) Role of endoglin in cellular responses to transforming growth factor-\u03b2. A comparative study with betaglycan. J Biol Chem 273:33011\u201333019","journal-title":"J Biol Chem"},{"key":"9101_CR43","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1046\/j.1432-1327.2000.01621.x","volume":"267","author":"SH Wong","year":"2000","unstructured":"Wong SH, Hamel L, Chevalier S, Philip A (2000) Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-\u03b2 signalling receptors. Eur J Biochem 267:5550\u20135560","journal-title":"Eur J Biochem"},{"key":"9101_CR44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcp.10200","volume":"194","author":"L Calabr\u00f2","year":"2003","unstructured":"Calabr\u00f2 L, Fonsatti E, Bellomo G, Alonci A, Colizzi F, Sigalotti L, Altomonte M, Musolino C, Maio M (2003) Differential levels of soluble endoglin (CD105) in myeloid malignancies. J Cell Physiol 194:171\u2013175","journal-title":"J Cell Physiol"},{"key":"9101_CR45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M","volume":"89","author":"C Li","year":"2000","unstructured":"Li C, Guo B, Wilson PB, Stewart A, Byrne G, Bundred N, Kumar S (2000) Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer. Int J Cancer 89:122\u2013126","journal-title":"Int J Cancer"},{"key":"9101_CR46","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992\u20131005","journal-title":"N Engl J Med"},{"key":"9101_CR47","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1074\/jbc.M306499200","volume":"279","author":"G Velasco-Loyden","year":"2004","unstructured":"Velasco-Loyden G, Arribas J, L\u00f3pez-Casillas F (2004) The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J Biol Chem 279:7721\u20137733","journal-title":"J Biol Chem"},{"key":"9101_CR48","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0021-9258(17)42126-0","volume":"269","author":"H Yamashita","year":"1994","unstructured":"Yamashita H, Ichijo H, Grimsby S, Mor\u00e9n A, ten Dijke P, Miyazono K (1994) Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-\u03b2. J Biol Chem 269:1995\u20132001","journal-title":"J Biol Chem"},{"key":"9101_CR49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(92)80853-9","volume":"300","author":"P Bork","year":"1992","unstructured":"Bork P, Sander C (1992) A large domain common to sperm receptors (Zp2 and Zp3) and TGF-\u03b2 type III receptor. FEBS Lett 300:237\u2013240","journal-title":"FEBS Lett"},{"key":"9101_CR50","doi-asserted-by":"crossref","first-page":"29197","DOI":"10.1074\/jbc.M111991200","volume":"277","author":"M Guerrero-Esteo","year":"2002","unstructured":"Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C (2002) Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-\u03b2 receptors I and II. J Biol Chem 277:29197\u201329209","journal-title":"J Biol Chem"},{"key":"9101_CR51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jmb.2006.10.015","volume":"365","author":"O Llorca","year":"2007","unstructured":"Llorca O, Trujillo A, Blanco FJ, Bernabeu C (2007) Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol 365:694\u2013705","journal-title":"J Mol Biol"},{"key":"9101_CR52","doi-asserted-by":"crossref","first-page":"25110","DOI":"10.1074\/jbc.M601288200","volume":"281","author":"RI Koleva","year":"2006","unstructured":"Koleva RI, Conley BA, Romero D, Riley KS, Marto JA, Lux A, Vary CP (2006) Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-\u03b2 receptors. J Biol Chem 281:25110\u201325123","journal-title":"J Biol Chem"},{"key":"9101_CR53","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/eji.1830230943","volume":"23","author":"T Bell\u00f3n","year":"1993","unstructured":"Bell\u00f3n T, Corb\u00ed A, Lastres P, Cal\u00e9s C, Cebri\u00e1n M, Vera S, Cheifetz S, Massague J, Letarte M, Bernab\u00e9u C (1993) Identification and expression of two forms of the human transforming growth factor-\u03b2-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 23:2340\u20132345","journal-title":"Eur J Immunol"},{"key":"9101_CR54","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.106.639161","volume":"114","author":"LW Laake van","year":"2006","unstructured":"van Laake LW, van den Driesche S, Post S, Feijen A, Jansen MA, Driessens MH, Mager JJ, Snijder RJ, Westermann CJ, Doevendans PA, van Echteld CJ, ten Dijke P, Arthur HM, Goumans MJ, Lebrin F, Mummery CL (2006) Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 114:2288\u20132297","journal-title":"Circulation"},{"key":"9101_CR55","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1242\/jcs.00470","volume":"116","author":"C Li","year":"2003","unstructured":"Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, Bernabeu C, Kumar S (2003) CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 116:2677\u20132685","journal-title":"J Cell Sci"},{"key":"9101_CR56","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1242\/jcs.002949","volume":"120","author":"M Scharpfenecker","year":"2007","unstructured":"Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, L\u00f6wik CW, ten Dijke P (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120:964\u2013972","journal-title":"J Cell Sci"},{"key":"9101_CR57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jcp.10170","volume":"193","author":"T Ota","year":"2002","unstructured":"Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, Miyazono K (2002) Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-\u03b2 in human umbilical vein endothelial cells. J Cell Physiol 193:299\u2013318","journal-title":"J Cell Physiol"},{"key":"9101_CR58","first-page":"1189","volume":"23","author":"C Li","year":"2003","unstructured":"Li C, Guo B, Ding S, Rius C, Langa C, Kumar P, Bernabeu C, Kumar S (2003) TNF\u03b1 down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF\u03b21. Anticancer Res 23:1189\u20131196","journal-title":"Anticancer Res"},{"key":"9101_CR59","doi-asserted-by":"crossref","first-page":"34486","DOI":"10.1074\/jbc.M011611200","volume":"276","author":"LM Botella","year":"2001","unstructured":"Botella LM, S\u00e1nchez-Elsner T, Rius C, Corb\u00ed A, Bernab\u00e9u C (2001) Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-\u03b2 stimulation. J Biol Chem 276:34486\u201334494","journal-title":"J Biol Chem"},{"key":"9101_CR60","doi-asserted-by":"crossref","first-page":"43799","DOI":"10.1074\/jbc.M207160200","volume":"277","author":"T S\u00e1nchez-Elsner","year":"2002","unstructured":"S\u00e1nchez-Elsner T, Botella LM, Velasco B, Langa C, Bernab\u00e9u C (2002) Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-\u03b2 pathways. J Biol Chem 277:43799\u201343808","journal-title":"J Biol Chem"},{"key":"9101_CR61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/eji.1830220216","volume":"22","author":"P Lastres","year":"1992","unstructured":"Lastres P, Bellon T, Caba\u00f1as C, Sanchez-Madrid F, Acevedo A, Gougos A, Letarte M, Bernabeu C (1992) Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol 22:393\u2013397","journal-title":"Eur J Immunol"},{"key":"9101_CR62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1095\/biolreprod51.3.405","volume":"51","author":"S St-Jacques","year":"1994","unstructured":"St-Jacques S, Forte M, Lye SJ, Letarte M (1994) Localization of endoglin, a transforming growth factor-\u03b2 binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 51:405\u2013413","journal-title":"Biol Reprod"},{"key":"9101_CR63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0021-9150(00)00422-6","volume":"153","author":"BA Conley","year":"2000","unstructured":"Conley BA, Smith JD, Guerrero-Esteo M, Bernabeu C, Vary CP (2000) Endoglin, a TGF-\u03b2 receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis 153:323\u2013335","journal-title":"Atherosclerosis"},{"key":"9101_CR64","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ydbio.2007.06.009","volume":"308","author":"ML Mancini","year":"2007","unstructured":"Mancini ML, Verdi JM, Conley BA, Nicola T, Spicer DB, Oxburgh LH, Vary CP (2007) Endoglin is required for myogenic differentiation potential of neural crest stem cells. Dev Biol 308:520\u2013533","journal-title":"Dev Biol"},{"key":"9101_CR65","doi-asserted-by":"crossref","first-page":"15468","DOI":"10.1073\/pnas.202614899","volume":"99","author":"CZ Chen","year":"2002","unstructured":"Chen CZ, Li M, de Graaf D, Monti S, G\u00f6ttgens B, Sanchez MJ, Lander ES, Golub TR, Green AR, Lodish HF (2002) Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci USA 99:15468\u201315473","journal-title":"Proc Natl Acad Sci USA"},{"key":"9101_CR66","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(03)00265-6","volume":"19","author":"CZ Chen","year":"2003","unstructured":"Chen CZ, Li L, Li M, Lodish HF (2003) The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells. Immunity 19:525\u2013533","journal-title":"Immunity"},{"key":"9101_CR67","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1242\/dev.002907","volume":"34","author":"RC Perlingeiro","year":"2007","unstructured":"Perlingeiro RC (2007) Endoglin is required for hemangioblast and early hematopoietic development. Development 34:3041\u20133048","journal-title":"Development"},{"key":"9101_CR68","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1634\/stemcells.2006-0602","volume":"25","author":"JL Moody","year":"2007","unstructured":"Moody JL, Singbrant S, Karlsson G, Blank U, Aspling M, Flygare J, Bryder D, Karlsson S (2007) Endoglin is not critical for hematopoietic stem cell engraftment and reconstitution but regulates adult erythroid development. Stem Cells 25:2809\u20132819","journal-title":"Stem Cells"},{"key":"9101_CR69","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/bjc.1996.593","volume":"74","author":"M Altomonte","year":"1996","unstructured":"Altomonte M, Montagner R, Fonsatti E, Colizzi F, Cattarossi I, Brasoveanu LI, Nicotra MR, Cattelan A, Natali PG, Maio M (1996) Expression and structural features of endoglin (CD105), a transforming growth factor \u03b21 and \u03b23 binding protein, in human melanoma. Br J Cancer 74:1586\u20131591","journal-title":"Br J Cancer"},{"key":"9101_CR70","first-page":"213","volume":"73","author":"R Henriksen","year":"1995","unstructured":"Henriksen R, Gobl A, Wilander E, Oberg K, Miyazono K, Funa K (1995) Expression and prognostic significance of TGF-\u03b2 isotypes, latent TGF-\u03b21 binding protein, TGF-\u03b2 type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab Invest 73:213\u2013220","journal-title":"Lab Invest"},{"key":"9101_CR71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00129785-200101020-00007","volume":"1","author":"B Jovanovic","year":"2001","unstructured":"Jovanovic B, Huang S, Liu YQ, Naguib KN, Bergan RC (2001) Am J PharmacoGenomics 1:145\u2013152","journal-title":"Am J PharmacoGenomics"},{"key":"9101_CR72","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1038\/sj.onc.1206117","volume":"21","author":"Y Liu","year":"2002","unstructured":"Liu Y, Jovanovic B, Pins M, Lee C, Bergan RC (2002) Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene 21:8272\u20138281","journal-title":"Oncogene"},{"key":"9101_CR73","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/sj.onc.1210533","volume":"26","author":"CS Craft","year":"2007","unstructured":"Craft CS, Romero D, Vary CP, Bergan RC (2007) Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway. Oncogene 26:7240\u20137250","journal-title":"Oncogene"},{"key":"9101_CR74","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1038\/sj.onc.1206841","volume":"22","author":"M Quintanilla","year":"2003","unstructured":"Quintanilla M, Ramirez JR, P\u00e9rez-G\u00f3mez E, Romero D, Velasco B, Letarte M, L\u00f3pez-Novoa JM, Bernab\u00e9u C (2003) Expression of the TGF-\u03b2 coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. Oncogene 22:5976\u20135985","journal-title":"Oncogene"},{"key":"9101_CR75","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1074\/jbc.274.15.9984","volume":"274","author":"A Lux","year":"1999","unstructured":"Lux A, Attisano L, Marchuk DA (1999) Assignment of transforming growth factor \u03b21 and \u03b23 and a third new ligand to the type I receptor ALK-1. J Biol Chem 274:9984\u20139992","journal-title":"J Biol Chem"},{"key":"9101_CR76","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1074\/jbc.274.2.584","volume":"274","author":"NP Barbara","year":"1999","unstructured":"Barbara NP, Wrana JL, Letarte M (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 274:584\u2013594","journal-title":"J Biol Chem"},{"key":"9101_CR77","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF\u03b2\/ALK5 signaling. Mol Cell 12:817\u2013828","journal-title":"Mol Cell"},{"key":"9101_CR78","first-page":"1337","volume":"24","author":"B Guo","year":"2004","unstructured":"Guo B, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S (2004) CD105 inhibits transforming growth factor-\u03b2-Smad3 signalling. Anticancer Res 24:1337\u20131345","journal-title":"Anticancer Res"},{"key":"9101_CR79","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1074\/jbc.M611062200","volume":"282","author":"O Scherner","year":"2007","unstructured":"Scherner O, Meurer SK, Tihaa L, Gressner AM, Weiskirchen R (2007) Endoglin differentially modulates antagonistic transforming growth factor-\u03b21 and BMP-7 signaling. J Biol Chem 282:13934\u201313943","journal-title":"J Biol Chem"},{"key":"9101_CR80","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","volume":"23","author":"F Lebrin","year":"2004","unstructured":"Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P (2004) Endoglin promotes endothelial cell proliferation and TGF-\u03b2\/ALK1 signal transduction. EMBO J 23:4018\u20134028","journal-title":"EMBO J"},{"key":"9101_CR81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1096\/fasebj.14.1.55","volume":"14","author":"C Li","year":"2000","unstructured":"Li C, Hampson IN, Hampson L, Kumar P, Bernabeu C, Kumar S (2000) CD105 antagonizes the inhibitory signaling of transforming growth factor \u03b21 on human vascular endothelial cells. FASEB J 14:55\u201364","journal-title":"FASEB J"},{"key":"9101_CR82","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcp.20311","volume":"204","author":"FJ Blanco","year":"2005","unstructured":"Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C (2005) Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-\u03b2 receptor complex. J Cell Physiol 204:574\u2013584","journal-title":"J Cell Physiol"},{"key":"9101_CR83","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ijc.11551","volume":"108","author":"X She","year":"2004","unstructured":"She X, Matsuno F, Harada N, Tsai H, Seon BK (2004) Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-\u03b2 in suppression of growth of human endothelial cells. Int J Cancer 108:251\u2013257","journal-title":"Int J Cancer"},{"key":"9101_CR84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cardiores.2005.06.009","volume":"68","author":"A Fernandez-L","year":"2005","unstructured":"Fernandez-L A, Sanz-Rodriguez F, Zarrabeitia R, P\u00e9rez-Molino A, Hebbel RP, Nguyen J, Bernab\u00e9u C, Botella LM (2005) Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res 68:235\u2013248","journal-title":"Cardiovasc Res"},{"key":"9101_CR85","doi-asserted-by":"crossref","first-page":"27800","DOI":"10.1074\/jbc.M503471200","volume":"280","author":"N Pece-Barbara","year":"2005","unstructured":"Pece-Barbara N, Vera S, Kathirkamathamby K, Liebner S, Di Guglielmo GM, Dejana E, Wrana JL, Letarte M (2005) Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor \u03b21 with higher affinity receptors and an activated ALK1 pathway. J Biol Chem 280:27800\u201327808","journal-title":"J Biol Chem"},{"key":"9101_CR86","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.RES.0000159936.38601.22","volume":"96","author":"M Toporsian","year":"2005","unstructured":"Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M (2005) A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96:684\u2013692","journal-title":"Circ Res"},{"key":"9101_CR87","doi-asserted-by":"crossref","unstructured":"Santibanez JF, Blanco FJ, Garrido-Martin EM, Sanz-Rodriguez F, Del Pozo MA, Bernabeu C (2008) Caveolin-1 interacts and cooperates with the transforming growth factor-\u03b2 type I receptor ALK1 in endothelial caveolae. Cardiovasc Res (in press)","DOI":"10.1093\/cvr\/cvm097"},{"key":"9101_CR88","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1074\/jbc.M008340200","volume":"276","author":"B Razani","year":"2001","unstructured":"Razani B, Zhang XL, Bitzer M, von Gersdorff G, B\u00f6ttinger EP, Lisanti MP (2001) Caveolin-1 regulates transforming growth factor (TGF)-\u03b2\/SMAD signaling through an interaction with the TGF-\u03b2 type I receptor. J Biol Chem 276:6727\u20136738","journal-title":"J Biol Chem"},{"key":"9101_CR89","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1126\/science.1062688","volume":"293","author":"M Drab","year":"2001","unstructured":"Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449\u20132452","journal-title":"Science"},{"key":"9101_CR90","doi-asserted-by":"crossref","first-page":"32858","DOI":"10.1074\/jbc.M400843200","volume":"271","author":"F Sanz-Rodriguez","year":"2004","unstructured":"Sanz-Rodriguez F, Guerrero-Esteo M, Botella LM, Banville D, Vary CP, Bernab\u00e9u C (2004) Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 271:32858\u201332868","journal-title":"J Biol Chem"},{"key":"9101_CR91","doi-asserted-by":"crossref","first-page":"27440","DOI":"10.1074\/jbc.M312561200","volume":"279","author":"BA Conley","year":"2004","unstructured":"Conley BA, Koleva R, Smith JD, Kacer D, Zhang D, Bernab\u00e9u C, Vary CP (2004) Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J Biol Chem 279:27440\u201327449","journal-title":"J Biol Chem"},{"key":"9101_CR92","doi-asserted-by":"crossref","first-page":"21507","DOI":"10.1074\/jbc.M700176200","volume":"282","author":"NY Lee","year":"2007","unstructured":"Lee NY, Blobe GC (2007) The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-\u03b2-mediated ERK activation and migration in endothelial cells. J Biol Chem 282:21507\u201321517","journal-title":"J Biol Chem"},{"key":"9101_CR93","doi-asserted-by":"crossref","first-page":"37069","DOI":"10.1074\/jbc.M608614200","volume":"281","author":"Q Meng","year":"2006","unstructured":"Meng Q, Lux A, Holloschi A, Li J, Hughes JM, Foerg T, McCarthy JE, Heagerty AM, Kioschis P, Hafner M, Garland JM (2006) Identification of Tctex2\u03b2, a novel dynein light chain family member that interacts with different transforming growth factor-\u03b2 receptors. J Biol Chem 281:37069\u201337080","journal-title":"J Biol Chem"},{"key":"9101_CR94","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/PL00012413","volume":"51","author":"E Torsney","year":"2002","unstructured":"Torsney E, Charlton R, Parums D, Collis M, Arthur HM (2002) Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 51:464\u2013470","journal-title":"Inflamm Res"},{"key":"9101_CR95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0925-4773(01)00562-7","volume":"110","author":"L Jonker","year":"2002","unstructured":"Jonker L, Arthur HM (2002) Endoglin expression in early development is associated with vasculogenesis and angiogenesis. Mech Dev 110:193\u2013196","journal-title":"Mech Dev"},{"key":"9101_CR96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/dev.111.1.131","volume":"111","author":"FA Millan","year":"1991","unstructured":"Millan FA, Denhez F, Kondaiah P, Akhurst RJ (1991) Embryonic gene expression patterns of TGF\u03b21, \u03b22 and \u03b23 suggest different developmental functions in vivo. Development 111:131\u2013143","journal-title":"Development"},{"key":"9101_CR97","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/dbio.1998.8905","volume":"199","author":"MJ Charng","year":"1998","unstructured":"Charng MJ, Frenkel PA, Lin Q, Yamada M, Schwartz RJ, Olson EN, Overbeek P, Schneider MD (1998) A constitutive mutation of ALK5 disrupts cardiac looping and morphogenesis in mice. Dev Biol 199:72\u201379","journal-title":"Dev Biol"},{"key":"9101_CR98","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1083\/jcb.141.3.805","volume":"141","author":"KK Hirschi","year":"1998","unstructured":"Hirschi KK, Rohovsky SA, D\u2019Amore PA (1998) PDGF, TGF-\u03b2, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1\/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805\u2013814","journal-title":"J Cell Biol"},{"key":"9101_CR99","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1242\/dev.01529","volume":"131","author":"RL Carvalho","year":"2004","unstructured":"Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, ten Dijke P, Arthur HM, Mummery CL (2004) Defective paracrine signalling by TGF\u03b2 in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131:6237\u20136247","journal-title":"Development"},{"key":"9101_CR100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jmg.2005.030833","volume":"43","author":"SA Abdalla","year":"2006","unstructured":"Abdalla SA, Letarte M (2006) Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43:97\u2013110","journal-title":"J Med Genet"},{"key":"9101_CR101","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1096\/fj.03-0197fje","volume":"18","author":"M Jerkic","year":"2004","unstructured":"Jerkic M, Rivas-Elena JV, Prieto M, Carr\u00f3n R, Sanz-Rodr\u00edguez F, P\u00e9rez-Barriocanal F, Rodr\u00edguez-Barbero A, Bernab\u00e9u C, L\u00f3pez-Novoa JM (2004) Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 18:609\u2013611","journal-title":"FASEB J"},{"key":"9101_CR102","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jmg.2005.035451","volume":"43","author":"TG Letteboer","year":"2006","unstructured":"Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ (2006) Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 43:371\u2013377","journal-title":"J Med Genet"},{"key":"9101_CR103","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363:852\u2013859","journal-title":"Lancet"},{"key":"9101_CR104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cardiores.2005.04.028","volume":"68","author":"M Letarte","year":"2005","unstructured":"Letarte M, McDonald ML, Li C, Kathirkamathamby K, Vera S, Pece-Barbara N, Kumar S (2005) Reduced endothelial secretion and plasma levels of transforming growth factor-\u03b21 in patients with hereditary hemorrhagic telangiectasia type 1. Cardiovasc Res 68:155\u2013164","journal-title":"Cardiovasc Res"},{"key":"9101_CR105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365:785\u2013799","journal-title":"Lancet"},{"key":"9101_CR106","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/01.ogx.0000146948.19308.c5","volume":"59","author":"JK Baxter","year":"2004","unstructured":"Baxter JK, Weinstein L (2004) HELLP syndrome: the state of the art. Obstet Gynecol Surv 59:838\u2013845","journal-title":"Obstet Gynecol Surv"},{"key":"9101_CR107","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","volume":"161","author":"JM Roberts","year":"1989","unstructured":"Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161:1200\u20131204","journal-title":"Am J Obstet Gynecol"},{"key":"9101_CR108","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1477-7827-2-53","volume":"2","author":"SJ Fisher","year":"2004","unstructured":"Fisher SJ (2004) The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2:53","journal-title":"Reprod Biol Endocrinol"},{"key":"9101_CR109","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672\u2013683","journal-title":"N Engl J Med"},{"key":"9101_CR110","doi-asserted-by":"crossref","unstructured":"Cruz-Gonzalez I, Pab\u00f3n P, Rodr\u00edguez-Barbero A, Mart\u00edn-Moreiras J, Pericacho M, S\u00e1nchez PL, Ramirez V, S\u00e1nchez-Ledesma M, Mart\u00edn-Herrero F, Jim\u00e9nez-Candil J, Maree AO, S\u00e1nchez-Rodr\u00edguez A, Mart\u00edn-Luengo C, L\u00f3pez-Novoa JM (2008) Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. J Cell Mol Med (in press)","DOI":"10.1111\/j.1582-4934.2008.00156.x"},{"key":"9101_CR111","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932\u2013936","journal-title":"Nature"},{"key":"9101_CR112","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335\u20132342","journal-title":"N Engl J Med"},{"key":"9101_CR113","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/pros.10083","volume":"51","author":"P Wikstr\u00f6m","year":"2002","unstructured":"Wikstr\u00f6m P, Lissbrant IF, Stattin P, Egevad L, Bergh A (2002) Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate 51:268\u2013275","journal-title":"Prostate"},{"key":"9101_CR114","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/sj.bjc.6603491","volume":"95","author":"MJ Beresford","year":"2006","unstructured":"Beresford MJ, Harris AL, Ah-See M, Daley F, Padhani AR, Makris A (2006) The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. Br J Cancer 95:1683\u20131688","journal-title":"Br J Cancer"},{"key":"9101_CR115","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1309\/X6NXYE57DLUE2NQ8","volume":"127","author":"YM El-Gohary","year":"2007","unstructured":"El-Gohary YM, Silverman JF, Olson PR, Liu YL, Cohen JK, Miller R, Saad RS (2007) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma. Am J Clin Pathol 127:572\u2013579","journal-title":"Am J Clin Pathol"},{"key":"9101_CR116","first-page":"224","volume":"96","author":"CA Brewer","year":"2000","unstructured":"Brewer CA, Setterdahl JJ, Li MJ, Johnston JM, Mann JL, McAsey ME (2000) Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 96:224\u2013228","journal-title":"Obstet Gynecol"},{"key":"9101_CR117","first-page":"1031","volume":"3","author":"BK Seon","year":"1997","unstructured":"Seon BK, Matsuno F, Haruta Y, Kondo M, Barcos M (1997) Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Clin Cancer Res 3:1031\u20131044","journal-title":"Clin Cancer Res"},{"key":"9101_CR118","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0959-8049(99)00335-4","volume":"36","author":"S Bredow","year":"2000","unstructured":"Bredow S, Lewin M, Hofmann B, Marecos E, Weissleder R (2000) Imaging of tumour neovasculature by targeting the TGF-\u03b2 binding receptor endoglin. Eur J Cancer 36:675\u2013681","journal-title":"Eur J Cancer"},{"key":"9101_CR119","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1038\/sj.onc.1206813","volume":"22","author":"E Fonsatti","year":"2003","unstructured":"Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M (2003) Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22:6557\u20136563","journal-title":"Oncogene"},{"key":"9101_CR120","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1096\/fj.02-0634rev","volume":"17","author":"SE Duff","year":"2003","unstructured":"Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984\u2013992","journal-title":"FASEB J"},{"key":"9101_CR121","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00001813-199703000-00004","volume":"8","author":"JA Maier","year":"1997","unstructured":"Maier JA, Delia D, Thorpe PE, Gasparini G (1997) In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11. Anticancer Drugs 8:238\u2013244","journal-title":"Anticancer Drugs"},{"key":"9101_CR122","first-page":"7846","volume":"61","author":"N Takahashi","year":"2001","unstructured":"Takahashi N, Haba A, Matsuno F, Seon BK (2001) Antiangiogenic therapy of established tumors in human skin\/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Cancer Res 61:7846\u20137754","journal-title":"Cancer Res"},{"key":"9101_CR123","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/eji.200424933","volume":"34","author":"GH Tan","year":"2004","unstructured":"Tan GH, Wei YQ, Tian L, Zhao X, Yang L, Li J, He QM, Wu Y, Wen YJ, Yi T, Ding ZY, Kan B, Mao YQ, Deng HX, Li HL, Zhou CH, Fu CH, Xiao F, Zhang XW (2004) Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol 34:2012\u20132021","journal-title":"Eur J Immunol"},{"key":"9101_CR124","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.dld.2006.04.014","volume":"38","author":"JG Jiao","year":"2006","unstructured":"Jiao JG, Li YN, Wang H, Liu Q, Cao JX, Bai RZ, Huang FY (2006) A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models. Dig Liver Dis 38:578\u2013587","journal-title":"Dig Liver Dis"},{"key":"9101_CR125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ijc.1505","volume":"94","author":"E Balza","year":"2001","unstructured":"Balza E, Castellani P, Zijlstra A, Neri D, Zardi L, Siri A (2001) Lack of specificity of endoglin expression for tumor blood vessels. Int J Cancer 94:579\u2013585","journal-title":"Int J Cancer"},{"key":"9101_CR126","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ijc.10378","volume":"99","author":"BK Seon","year":"2002","unstructured":"Seon BK (2002) Expression of endoglin (CD105) in tumor blood vessels. Int J Cancer 99:310\u2013311","journal-title":"Int J Cancer"},{"key":"9101_CR127","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1073\/pnas.0611660104","volume":"104","author":"MR Kano","year":"2007","unstructured":"Kano MR, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M, Hirakawa K, Ouchi Y, Nishiyama N, Kataoka K, Miyazono K (2007) Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-\u03b2 signaling. Proc Natl Acad Sci USA 104:3460\u20133465","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-008-9101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-008-9101-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-008-9101-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T14:43:33Z","timestamp":1684248213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-008-9101-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,19]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9101"],"URL":"https:\/\/doi.org\/10.1007\/s10456-008-9101-9","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,19]]}}}